Tomomi Masuda

Maebashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

PPARα-Dependent and Independent Mechanisms Are Complexly Involved in the Ameliorative Effect of a Dietary Supplement Containing Lactic Acid Bacteria in a Dry Eye Mouse Model.

PPARα-Dependent and Independent Mechanisms Are Complexly Involved in the Ameliorative Effect of a Dietary Supplement Containing Lactic Acid Bacteria in a Dry Eye Mouse Model.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: February 04, 2026

Exogenous Lipoid Pneumonia Caused by E-Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case Report.

Exogenous Lipoid Pneumonia Caused by E-Cigarette Use Following Exposure to Oil Spray and Waterproofing Spray: A Case Report.

Journal: Clinical case reports

Published: November 26, 2025

A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.

A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.

Journal: Thoracic cancer

Published: September 10, 2024

Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.

Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.

Journal: Cancers

Published: December 23, 2023

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.

Journal: Respiratory medicine case reports

Published: August 16, 2022

A pregnant woman with severe dyspnoea.

A pregnant woman with severe dyspnoea.

Journal: Breathe (Sheffield, England)

Published: January 23, 2022

Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).

Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).

Journal: Thoracic cancer

Published: April 13, 2021

Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations.

Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations.

Journal: Thoracic cancer

Published: May 04, 2020

Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC.

Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC.

Journal: Anticancer research

Published: January 13, 2020

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: October 07, 2019

Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer.

Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer.

Journal: Oncology letters

Published: November 02, 2018

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: November 12, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026